Shield Therapeutics Future Growth

Future criteria checks 6/6

Shield Therapeutics is forecast to grow earnings and revenue by 86.9% and 47.7% per annum respectively. EPS is expected to grow by 76.2% per annum. Return on equity is forecast to be 95% in 3 years.

Key information

86.9%

Earnings growth rate

76.2%

EPS growth rate

Pharmaceuticals earnings growth14.7%
Revenue growth rate47.7%
Future return on equity95.0%
Analyst coverage

Low

Last updated22 Feb 2024

Recent future growth updates

Recent updates

Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation

Mar 02
Here's Why We're Watching Shield Therapeutics' (LON:STX) Cash Burn Situation

What Does The Future Hold For Shield Therapeutics plc (LON:STX)? These Analysts Have Been Cutting Their Estimates

May 06
What Does The Future Hold For Shield Therapeutics plc (LON:STX)? These Analysts Have Been Cutting Their Estimates

Shield Therapeutics (LON:STX) Shareholders Have Enjoyed An Impressive 111% Share Price Gain

Mar 15
Shield Therapeutics (LON:STX) Shareholders Have Enjoyed An Impressive 111% Share Price Gain

We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow

Jan 27
We're Interested To See How Shield Therapeutics (LON:STX) Uses Its Cash Hoard To Grow

Trade Alert: The CEO & Director Of Shield Therapeutics plc (LON:STX), Timothy Watts, Has Just Spent UK£70k Buying 22% More Shares

Dec 15
Trade Alert: The CEO & Director Of Shield Therapeutics plc (LON:STX), Timothy Watts, Has Just Spent UK£70k Buying 22% More Shares

Earnings and Revenue Growth Forecasts

AIM:STX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026183N/A31N/A1
12/31/20251321514172
12/31/202467-14-16-133
12/31/202319-32-35-323
6/30/20237-49-30-28N/A
3/31/20236-49-27-24N/A
12/31/20225-49-23-21N/A
9/30/20224-36-23-20N/A
6/30/20224-30-31-27N/A
3/31/20223-29-29-26N/A
12/31/20212-27-27-25N/A
9/30/20212-22-21-20N/A
6/30/20213-18-16-16N/A
3/31/20219-11-9-9N/A
12/31/202014-4-2-2N/A
9/30/202013-3-1-1N/A
6/30/202011-200N/A
3/31/20206-6-4-3N/A
12/31/20191-12-7-5N/A
9/30/20198-4-11N/A
6/30/201915346N/A
3/31/201915003N/A
12/31/201815-2-40N/A
9/30/20188-13-14-9N/A
6/30/20181-24-24-19N/A
3/31/20181-26-26-21N/A
12/31/20171-26-26-22N/A
9/30/20171-24-25-21N/A
6/30/20170-21-24-19N/A
3/31/20170-19N/A-16N/A
12/31/20160-19N/A-13N/A
9/30/20160-12N/A-12N/A
6/30/20160-4N/A-10N/A
3/31/20160-19N/A-8N/A
12/31/2015N/A-35N/A-6N/A
9/30/20150-41N/A-5N/A
6/30/20150-49N/A-4N/A
3/31/20150-33N/A-5N/A
12/31/20140-20N/A-5N/A
12/31/20130-7N/A-5N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: STX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.6%).

Earnings vs Market: STX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: STX is expected to become profitable in the next 3 years.

Revenue vs Market: STX's revenue (47.7% per year) is forecast to grow faster than the UK market (3.3% per year).

High Growth Revenue: STX's revenue (47.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: STX's Return on Equity is forecast to be very high in 3 years time (95%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.